Sierra Ocean’s Vaxcyte PCVX Stock Holding History

Sierra Ocean’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33	Closed	-$1.25K	–	1095
2025 Q1	$1.25K	Buy	33 +12	+57%	+$959	﹤0.01%	870
2024 Q4	$1.72K	Buy	+21	New	+$2.08K	﹤0.01%	809

Other funds holding PCVX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Sierra Ocean's PCVX Position: Q2 2025 in Review

Sierra Ocean sold out of Vaxcyte (PCVX) in Q2 2025, closing a stake of 33 shares — an estimated $1.25K sold.

Sierra Ocean first reported a position in PCVX in Q4 2024 and held it in 2 quarters. The position peaked at $1.72K in Q4 2024. 294 funds tracked by Wall St. Rank hold PCVX as of Q2 2025.

Sierra Ocean reported no remaining Vaxcyte position as of Q2 2025 after selling out during the quarter.
Sierra Ocean sold 33 Vaxcyte shares in Q2 2025, an estimated $1.25K.
Sierra Ocean first reported a position in Vaxcyte in Q4 2024 and held it in 2 quarters.
Sierra Ocean's Vaxcyte position peaked at $1.72K in Q4 2024.
294 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2025.

Based on Sierra Ocean's 13F filing for Q2 2025, filed 7 Aug 2025.